Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells

Acquisition of platinum resistance following first line platinum/taxane therapy is commonly observed in ovarian cancer patients and prevents clinical effectiveness. There are few options to prevent platinum resistance; however, demethylating agents have been shown to resensitize patients to platinum...

Descripción completa

Detalles Bibliográficos
Autores principales: Granados, Michaela L., Hudson, Laurie G., Samudio-Ruiz, Sabrina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564275/
https://www.ncbi.nlm.nih.gov/pubmed/26351843
http://dx.doi.org/10.1371/journal.pone.0136893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564275/
https://www.ncbi.nlm.nih.gov/pubmed/26351843
http://dx.doi.org/10.1371/journal.pone.0136893

Ejemplares similares